KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Range Low Price High Price Comment
30 days $1.41 $2.35 Friday, 26th Apr 2024 CYCC stock ended at $1.51. This is 5.63% less than the trading day before Thursday, 25th Apr 2024. During the day the stock fluctuated 6.85% from a day low at $1.46 to a day high of $1.56.
90 days $1.41 $3.08
52 weeks $1.41 $13.20

Historical Cyclacel Pharmaceuticals prices

Date Open High Low Close Volume
Jun 11, 2020 $4.74 $4.87 $4.41 $4.44 304 147
Jun 10, 2020 $5.17 $5.18 $4.86 $4.97 213 153
Jun 09, 2020 $5.04 $5.26 $5.01 $5.15 199 814
Jun 08, 2020 $4.82 $5.24 $4.75 $5.16 552 758
Jun 05, 2020 $4.81 $4.95 $4.76 $4.88 399 217
Jun 04, 2020 $4.76 $4.95 $4.71 $4.81 369 057
Jun 03, 2020 $4.90 $4.98 $4.69 $4.83 517 550
Jun 02, 2020 $5.06 $5.13 $4.88 $4.91 373 975
Jun 01, 2020 $4.97 $5.18 $4.91 $5.05 315 373
May 29, 2020 $5.31 $5.37 $4.90 $5.02 704 947
May 28, 2020 $5.44 $5.62 $5.34 $5.40 218 382
May 27, 2020 $5.58 $5.74 $5.20 $5.63 730 198
May 26, 2020 $5.95 $5.95 $5.41 $5.84 1 035 710
May 22, 2020 $5.36 $5.69 $5.16 $5.36 1 890 043
May 21, 2020 $4.59 $5.29 $4.57 $5.17 2 218 214
May 20, 2020 $4.45 $4.65 $4.30 $4.59 719 125
May 19, 2020 $4.17 $4.77 $4.08 $4.37 3 475 564
May 18, 2020 $4.13 $4.17 $4.06 $4.12 509 134
May 15, 2020 $4.13 $4.24 $4.10 $4.11 393 891
May 14, 2020 $4.08 $4.22 $4.07 $4.20 699 303
May 13, 2020 $4.67 $4.89 $4.05 $4.22 7 907 395
May 12, 2020 $4.15 $4.30 $4.08 $4.13 696 875
May 11, 2020 $4.12 $4.17 $4.07 $4.17 471 223
May 08, 2020 $4.10 $4.18 $4.07 $4.12 474 653
May 07, 2020 $4.07 $4.19 $4.05 $4.09 349 688
Click to get the best stock tips daily for free!

About Cyclacel Pharmaceuticals

Cyclacel Pharmaceuticals Cyclacel Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer and other proliferative diseases. The company's development programs include fadraciclib, a cyclin dependent kinase Inhibitors (CDK) that is in Phase 1/2 clinical trial for the treatment of solid tumors, as well as in combination with venetoclax to treat relapsed or refractory chronic lymphocytic leukemia; and CYC140, a polo-... CYCC Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT